# The Medicines (Products for Human Use — Fees) Regulations 1995, Paragraph 1: Marketing authorizations


Subject to paragraphs 2 to 6 inclusive, the fee payable under regulation 14(3) in connection with the holding of a marketing authorization relating to a medicinal product of a kind described in Column 1 of the following Table shall be the appropriate fee specified in the corresponding entry in Column 2 of that Table.
TABLE
Column 1
Column 2
Kind of product
Fee payable
1 New Active Substance
1 £11,900
2 Other kinds of Medicinal Product—
(a) Any product (not being a derivative of a new active substance) in respect of which a marketing authorization has been granted in consequence of a complex application submitted on or after 1st April 1989
2 (a) £5,950
(b) Prescription Only Medicine
(i) Standard Fee
2 (b) (i) £1,075
(ii) Reduced Rate Fee
2 (b) (ii) £535
(iii) Maintenance Fee
2 (b) (iii) £180
(c) Pharmacy Medicine
(i) Standard Fee
2 (c) (i) £535
(ii) Reduced Rate Fee
2 (c) (ii) £270
(iii) Maintenance Fee
2 (c) (iii) £120
(d) General Sale List Medicine
(i) Standard Fee
2 (d) (i) £240
(ii) Reduced Rate Fee
2 (d) (ii) £120
(iii) Maintenance Fee
2 (d) (iii) £90
(e) Herbal Remedy
2 (e) £60
(f) Homoeopathic Medicinal Product or Authroposophic Product
2 (f) £30

---
Source: https://www.legislation.gov.uk/uksi/1995/1116/schedule/3/part/III/paragraph/1 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-1995/schedule-3/part-III/paragraph-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.